Publisher： Adis International
ISSN： 0114-9954
Source： Reactions Weekly, Vol.1, Iss.1335, 2011-01, pp. : 25-26
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Infliximab: Opportunistic infections leading to multiorgan failure and death: case report
Reactions Weekly, Vol. 1, Iss. 1231, 2008-01 ,pp. :
Access to resources
Recommend
Adalimumab/efalizumab/infliximab: Psoriasis: 5 case reports
Reactions Weekly, Vol. 1, Iss. 1210, 2008-01 ,pp. :
Adalimumab/infliximab: Tuberculosis flare: 5 case reports
Reactions Weekly, Vol. 1, Iss. 1192, 2008-01 ,pp. :
Etanercept/infliximab: Sarcoidosis: 5 case reports
Reactions Weekly, Vol. 1, Iss. 1367, 2011-01 ,pp. :
Adalimumab/infliximab: Histoplasmosis: 5 case reports
Reactions Weekly, Vol. 1, Iss. 1336, 2011-01 ,pp. :